Lavipharm S.A. Stock

Equities

LAVI

GRS246003008

Pharmaceuticals

Delayed Athens S.E. 04:26:41 2024-04-26 am EDT 5-day change 1st Jan Change
0.87 EUR +4.82% Intraday chart for Lavipharm S.A. +6.36% +9.17%
Sales 2022 46.01M 49.36M Sales 2023 50.93M 54.65M Capitalization 134M 143M
Net income 2022 - 0 Net income 2023 1M 1.07M EV / Sales 2022 1.81 x
Net Debt 2022 18.93M 20.31M Net Debt 2023 24.04M 25.8M EV / Sales 2023 3.1 x
P/E ratio 2022
9.91 x
P/E ratio 2023
71.4 x
Employees 307
Yield 2022 *
-
Yield 2023
-
Free-Float 38.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.41%
1 week+4.04%
Current month-4.06%
1 month-4.71%
3 months-5.35%
6 months+39.34%
Current year+6.78%
More quotes
1 week
0.82
Extreme 0.82
0.87
1 month
0.78
Extreme 0.78
0.91
Current year
0.76
Extreme 0.76
0.96
1 year
0.39
Extreme 0.388
0.96
3 years
0.35
Extreme 0.346
2.22
5 years
0.35
Extreme 0.346
2.22
10 years
0.16
Extreme 0.162
2.22
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 21-11-30
Compliance Officer - -
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member - -
Chairman 84 08-12-31
Director/Board Member - 02-12-31
More insiders
Date Price Change Volume
24-04-26 0.87 +4.82% 24 500
24-04-25 0.83 -1.89% 91,288
24-04-24 0.846 -1.05% 125,020
24-04-23 0.855 +0.94% 123,376
24-04-22 0.847 +3.67% 120,265

Delayed Quote Athens S.E., April 26, 2024 at 03:51 am EDT

More quotes
Lavipharm SA is a Greek commercial and industrial enterprise engaged in the development, manufacture, marketing and distribution of pharmaceutical, cosmetic and over-the-counter (OTC) products. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the brand names of Castalia Soins Dermocosmetiques and Laviderm Active Technology and are used for skin, face and body care, as well as for scalp and hair problems. Its OTC products include cold and flu remedies, oral care, dermatological products, condoms, antiseptics, analgesics, laxatives and gynecology products. It is the parent company of Lavipharm Group of Companies. In January 2014, Robertet SA acquired together with CODIF the HITEX company, specialized in subcontracting of carbon dioxide extraction, from Lavipharm SA.
More about the company